GoodRx Holdings (GDRX) Invested Capital (2019 - 2026)

GoodRx Holdings has disclosed Invested Capital across 8 years of filings, most recently posting $1.1 billion for Q1 2026.

• Invested Capital for Q1 2026 came in at $1.1 billion, down 3.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 billion (down 3.12% YoY), and the FY2025 annual result was $1.1 billion, down 9.19% from the prior year.
• Invested Capital came in at $1.1 billion for Q1 2026 at GoodRx Holdings, roughly flat from $1.1 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $1.6 billion in Q2 2023 to a low of $793.5 million in Q1 2022.
• The 5-year median for Invested Capital is $1.1 billion (2025), against an average of $1.2 billion.
• Across the five-year window, Invested Capital surged 93.23% in 2023 and fell 22.72% in 2024, its largest moves.
• GoodRx Holdings' Invested Capital stood at $1.5 billion in 2022, then slipped by 3.75% to $1.4 billion in 2023, then decreased by 14.25% to $1.2 billion in 2024, then decreased by 9.19% to $1.1 billion in 2025, then increased by 0.44% to $1.1 billion in 2026.
• The last three Invested Capital figures came in at $1.1 billion (Q1 2026), $1.1 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.